Academy Capital Management’s PROVECTUS BIOPHARMACEUTICALS, INC. (DE) PVCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-20,000
| Closed | -$1.02K | – | 39 |
|
|
2026
Q1 | $1.02K | Hold |
20,000
| – | – | ﹤0.01% | 37 |
|
|
2025
Q4 | $1.12K | Hold |
20,000
| – | – | ﹤0.01% | 41 |
|
|
2025
Q3 | $1.78K | Hold |
20,000
| – | – | ﹤0.01% | 41 |
|
|
2025
Q2 | $1.5K | Hold |
20,000
| – | – | ﹤0.01% | 40 |
|
|
2025
Q1 | $2K | Hold |
20,000
| – | – | ﹤0.01% | 39 |
|
|
2024
Q4 | $2.4K | Hold |
20,000
| – | – | ﹤0.01% | 41 |
|
|
2024
Q3 | $1.96K | Hold |
20,000
| – | – | ﹤0.01% | 32 |
|
|
2024
Q2 | $2.52K | Hold |
20,000
| – | – | ﹤0.01% | 34 |
|
|
2024
Q1 | $3.66K | Hold |
20,000
| – | – | ﹤0.01% | 32 |
|
|
2023
Q4 | $1.92K | Hold |
20,000
| – | – | ﹤0.01% | 33 |
|
|
2023
Q3 | $1.69K | Hold |
20,000
| – | – | ﹤0.01% | 32 |
|
|
2023
Q2 | $2.26K | Hold |
20,000
| – | – | ﹤0.01% | 35 |
|
|
2023
Q1 | $3K | Hold |
20,000
| – | – | ﹤0.01% | 33 |
|
|
2022
Q4 | $2.17K | Hold |
20,000
| – | – | ﹤0.01% | 36 |
|
|
2022
Q3 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 36 |
|
|
2022
Q2 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 37 |
|
|
2022
Q1 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 37 |
|
|
2021
Q4 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 38 |
|
|
2021
Q3 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 39 |
|
|
2021
Q2 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 28 |
|
|
2021
Q1 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 34 |
|
|
2020
Q4 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 28 |
|
|
2020
Q3 | $1K | Buy |
+20,000
| New | +$1K | ﹤0.01% | 34 |
|
|
2020
Q2 | – | Sell |
-20,000
| Closed | -$1K | – | 39 |
|
|
2020
Q1 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 36 |
|
|
2019
Q4 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 38 |
|
|
2019
Q3 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 39 |
|
|
2019
Q2 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 36 |
|
|
2019
Q1 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 38 |
|
|
2018
Q4 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 38 |
|
|
2018
Q3 | $1K | Buy |
+20,000
| New | +$1K | ﹤0.01% | 37 |
|
|
2018
Q2 | – | Sell |
-20,000
| Closed | -$1K | – | 42 |
|
|
2018
Q1 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 39 |
|
|
2017
Q4 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 36 |
|
|
2017
Q3 | $0 | Buy |
+20,000
| New | – | ﹤0.01% | 40 |
|
|
2016
Q4 | – | Sell |
-20,000
| Closed | -$1K | – | 42 |
|
|
2016
Q3 | $1K | Hold |
20,000
| – | – | ﹤0.01% | 41 |
|
|
2016
Q2 | $6K | Hold |
20,000
| – | – | ﹤0.01% | 43 |
|
|
2016
Q1 | $7K | Buy |
+20,000
| New | +$8.24K | ﹤0.01% | 42 |
|
|
2014
Q3 | – | Sell |
-20,000
| Closed | -$17K | – | 43 |
|
|
2014
Q2 | $17K | Buy |
+20,000
| New | +$24K | ﹤0.01% | 40 |
|
Other funds holding PVCT
Academy Capital Management's PVCT Position: Q2 2026 in Review
Academy Capital Management sold out of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) in Q2 2026, closing a stake of 20,000 shares — an estimated $1.02K sold.
Academy Capital Management first reported a position in PVCT in Q2 2014 and held it in 37 quarters. The position peaked at $17K in Q2 2014. 4 funds tracked by Wall St. Rank hold PVCT as of Q2 2026.
- Academy Capital Management reported no remaining PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position as of Q2 2026 after selling out during the quarter.
- Academy Capital Management sold 20,000 PROVECTUS BIOPHARMACEUTICALS, INC. (DE) shares in Q2 2026, an estimated $1.02K.
- Academy Capital Management first reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in Q2 2014 and held it in 37 quarters.
- Academy Capital Management's PROVECTUS BIOPHARMACEUTICALS, INC. (DE) position peaked at $17K in Q2 2014.
- 4 funds tracked by Wall St. Rank held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) as of Q2 2026.
Based on Academy Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.